Nektar Therapeutics Unearned Premium on Insurance Contract (Quarterly) Insights

Nektar Therapeutics (NKTR)

37.38 +0.85 (+2.33%) USD | NASDAQ | Jan 23, 14:29

View Unearned Premium on Insurance Contract (Quarterly) for NKTR.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Unearned Premium on Insurance Contract (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Unearned Premium on Insurance Contract (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Unearned Premium on Insurance Contract (Quarterly) Benchmarks

Start Trial

Rigel Pharmaceuticals, Inc.	--
Insmed, Inc.	--
Eli Lilly & Co.	--
Ironwood Pharmaceuticals, Inc.	--
Lyell Immunopharma, Inc.	--